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Introduction
Sarcoidosis is a granulomatous disease possibly affecting
all organ systems. Less than 10% of sarcoidosis patients
develop symptomatic neurological involvement. Although
muscular non-caseating granulomas (NCGs) can be found
in up to 75% of sarcoidosis patients, muscular symptoms
develop only in less than 0.5% of sarcoidosis patients.
Corticosteroids (CS) are the mainstay of medical therapy,
but their effect on chronic myopathy is not consistent.
Additive immunosuppressive therapy with azathioprine,
cyclophosphamide, methotrexate, or chloroquine may be
necessary in patients inadequately responding to CSs.
Case report
A pathological routine x-ray of an asymptomatic 43-year-
old farmer led to a pulmonary CT, which showed mediast-
inal and hilar lymphadenopathy. Sporadic epitheloid cells
were found in lymph node biopsy. Bronchoalveolar lavage
contained predominantly lymphocytes with a moderately
elevated CD4/CD8 ratio (3.6). Tuberculosis-PCR and
-culture were negative. Spirometry demonstrated only
marginal obstruction. Because of iridocyclitis, predniso-
lone therapy (100 mg/d for two weeks, 50 mg/d for two
months, 25 mg/d for six more months, then 30 mg/d) was
initiated. After five months of CS therapy, the patient first
experienced stabbing pain (up to 3 out of 10 according to
the visual analog scale, VAS) in the left thigh without par-
esis. Six more months later he presented with pain aggra-
vation (VAS: up to 5) and additional moderate paresis of
left hip flexion and -extension. MRI demonstrated a slight
T2 (TIRM) hyperintensity in the left vastus lateralis mus-
cle. Electromyography showed spontaneous fibrillation
and positive sharp waves with normal motor unit poten-
tials. A muscle biopsy illustrated two processes: an inflam-
matory myopathy with prominent endomysial and
perimysial infiltrations (mainly CD4-lymphocytes, some
multinucleated giant cells and epitheloid cells) and
pronounced neurogenic changes (grouplike atrophy of
muscle fibers and florid disintegration of muscle fibers).
Laboratory analysis showed elevated creatine kinase (893
U/l with an upper limit (UL) of 200 U/l), and lysozyme
(22.1 mg/l with UL of 17.6). Four weeks after the muscle
biopsy, he still suffered from stinging pain in the left vastus
lateralis muscle sensitive to activity and pressure (VAS: up
to 8) despite medical therapy with diclofenac (150 mg/d)
and hydromorphone (4-5 mg/d). He had no signs of
arthritis or of cardiac, pulmonary, and visual involvement;
lupus pernio was not visible. Oral methylprednisolone was
increased to 60 mg per day. Five weeks later, he addition-
ally presented stabbing pain in the left semitendinosus
muscle with new pain-related moderate paresis of foot
dorsal extension, foot plantar flexion and adduction of the
left hip. Another inpatient stay for MRI, EMG, NCS, nerve
biopsy, semitendinosus muscle biopsy, laboratory analysis
and additive immunosuppressive therapy is planned
(results will be presented on the congress).
Discussion
Chronic symptomatic neuromuscular sarcoidosis is often
refractory to medical therapy and potentially leading to
severe and permanent disability. Only little data are avail-
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